We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+15.41%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.93B
AUM Growth
+$1.24B
Cap. Flow
+$454M
Cap. Flow %
6.54%
Top 10 Hldgs %
16.4%
Holding
1,110
New
146
Increased
497
Reduced
266
Closed
160

Top Buys

Rank Stock Value
1
NVR icon
NVR
NVR
+$34.9M
2
SBAC icon
SBA Communications
SBAC
+$31.5M
3
LII icon
Lennox International
LII
+$29.1M
4
MCK icon
McKesson
MCK
+$24.8M
5
CABO icon
Cable One
CABO
+$23.9M

Sector Composition

Rank Sector Weight
1 Technology 19.87%
2 Financials 16.58%
3 Consumer Discretionary 13.8%
4 Industrials 12.36%
5 Healthcare 10.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QEP
1076
DELISTED
QEP RESOURCES, INC.
QEP
-430,264
Closed -$2.42M
ZAGG
1077
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
-33,500
Closed -$328K
NBL
1078
DELISTED
Noble Energy, Inc.
NBL
-84,460
Closed -$1.58M
MNTA
1079
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
-32,862
Closed -$363K
TTPH
1080
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
-13,233
Closed -$299K
BGG
1081
DELISTED
Briggs & Stratton Corp.
BGG
-214,116
Closed -$2.8M
RTW
1082
DELISTED
RTW Retailwinds, Inc.
RTW
-161,087
Closed -$456K
CHK
1083
DELISTED
Chesapeake Energy Corporation
CHK
-1,075
Closed -$451K
WBC
1084
DELISTED
WABCO HOLDINGS INC.
WBC
-25,088
Closed -$2.69M
UNT
1085
DELISTED
UNIT Corporation
UNT
-11,200
Closed -$160K
RARX
1086
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
-10,736
Closed -$195K
CFRX
1087
DELISTED
ContraFect Corporation
CFRX
-21
Closed -$25K
SMTA
1088
DELISTED
Spirit MTA REIT Common Shares of Beneficial Interest
SMTA
-91,646
Closed -$653K
ONCE
1089
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
-22,040
Closed -$863K
VSI
1090
DELISTED
Vitamin Shoppe Inc.
VSI
-33,635
Closed -$159K
VSM
1091
DELISTED
Versum Materials, Inc.
VSM
-7,700
Closed -$213K
MSL
1092
DELISTED
Midsouth Bancorp, Inc.
MSL
-12,063
Closed -$128K
WAGE
1093
DELISTED
WageWorks, Inc.
WAGE
-92,767
Closed -$2.52M
LEXEA
1094
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
-26,950
Closed -$1.05M
QTNA
1095
DELISTED
Quantenna Communications, Inc. Common Stock
QTNA
-255,722
Closed -$3.67M
INSY
1096
DELISTED
Insys Therapeutics, Inc.
INSY
-79,700
Closed -$279K
TIER
1097
DELISTED
TIER REIT, Inc.
TIER
-118,594
Closed -$2.45M
ULTI
1098
DELISTED
Ultimate Software Group Inc
ULTI
-10,335
Closed -$2.53M
BNCL
1099
DELISTED
Beneficial Bancorp, Inc.
BNCL
-149,827
Closed -$2.14M
HDP
1100
DELISTED
Hortonworks, Inc.
HDP
-279,648
Closed -$4.03M

Similar funds

Jacobs Levy Equity Management's Q1 2019 Portfolio in Review

As of Q1 2019, Jacobs Levy Equity Management held 1,110 positions worth $6.93B, up 22% from $5.69B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Jacobs Levy Equity Management deployed $454M of net new capital in Q1 2019, opening 146 new positions and adding to 497 existing holdings. Its largest new stake was AbbVie: 282,010 shares worth $22.7M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $52.7M trimmed.

  • Jacobs Levy Equity Management's largest Q1 2019 buy was AbbVie: 282,010 shares worth $22.7M.
  • Jacobs Levy Equity Management added most to NVR in Q1 2019, an estimated $34.9M increase.
  • Jacobs Levy Equity Management's biggest Q1 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $52.7M.
  • Jacobs Levy Equity Management fully exited Celgene Corp in Q1 2019, selling an estimated $55.8M.
  • Jacobs Levy Equity Management's ten largest holdings make up 16% of its $6.93B portfolio in Q1 2019.
  • Jacobs Levy Equity Management opened 146 new positions and closed 160 in Q1 2019.
  • Jacobs Levy Equity Management's portfolio value rose 22% quarter-over-quarter to $6.93B.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2019, filed 14 May 2019.